Lista de obras - Ana-Maria Orbai - Dominio Público Uruguay

"Stiffness has different meanings, I think, to everyone": examining stiffness from the perspective of people living with rheumatoid arthritis

artículo científico publicado en 2014

A Multicenter Nominal Group Study to Rank Outcomes Important to Patients, and Their Representation in Existing Composite Outcome Measures for Psoriatic Arthritis

artículo científico publicado en 2017

A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiative ⬇️

artículo científico publicado en 2017

Achieving minimal disease activity in psoriatic arthritis predicts meaningful improvements in patients’ health-related quality of life and productivity

article

Advancing Stiffness Measurement in Rheumatic Disease: Report from the Stiffness Special Interest Group at OMERACT 2018

scientific article published on 15 February 2019

Anti-C1q antibodies in systemic lupus erythematosus

artículo científico publicado en 2014

Brief report: antisynthetase syndrome-associated myocarditis

artículo científico publicado en 2014

Building a Citizen Pscientist: Advancing Patient-Centered Psoriasis Research by Empowering Patients as Contributors and Analysts

artículo científico publicado en 2018

Classification and Outcome Measures for Psoriatic Arthritis

article

Combining online and in-person methods to evaluate the content validity of PROMIS fatigue short forms in rheumatoid arthritis

article

Comparing the patient reported physical function outcome measures in a real-life international cohort of patients with psoriatic arthritis

scientific article published on 21 January 2020

Content and Face Validity and Feasibility of 5 Candidate Instruments for Psoriatic Arthritis Randomized Controlled Trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting

scientific article published on 1 June 2018

Content validity of psoriatic arthritis composite indices: anchoring with the patient perspective and the core domain set

artículo científico publicado en 2020

Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working Group

artículo científico publicado en 2017

Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus

artículo científico publicado en 2012

Determinants of Patient-Reported Psoriatic Arthritis Impact of Disease: An Analysis of the Association with Gender in 458 Patients from 14 Countries

artículo científico publicado en 2019

Effect of Secukinumab on the Different GRAPPA-OMERACT Core Domains in Psoriatic Arthritis: A Pooled Analysis of 2049 Patients

artículo científico publicado en 2019

Effect of filgotinib on health-related quality of life in active psoriatic arthritis: a randomized phase 2 trial (EQUATOR)

scientific article published on 18 October 2019

Efficacy and Safety of Ixekizumab in Patients with Psoriatic Arthritis and Inadequate Response to TNF Inhibitors: 3-Year Follow-Up (SPIRIT-P2)

artículo científico publicado en 2020

Endorsement of the 66/68 Joint Count for the Measurement of Musculoskeletal Disease Activity: OMERACT 2018 Psoriatic Arthritis Workshop Report

scientific article published on 15 February 2019

Enhanced Patient Involvement and the Need to Revise the Core Set - Report from the Psoriatic Arthritis Working Group at OMERACT 2014

artículo científico

Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare Workshop

artículo científico publicado en 2014

Fatigue numeric rating scale validity, discrimination and responder definition in patients with psoriatic arthritis

artículo científico publicado en 2020

Feasibility and Domain Validation of Rheumatoid Arthritis (RA) Flare Core Domain Set: Report of the OMERACT 2014 RA Flare Group Plenary

artículo científico publicado en 2015

GRAPPA-OMERACT initiative to standardise outcomes in psoriatic arthritis clinical trials and longitudinal observational studies

artículo científico publicado en 2017

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis

artículo científico publicado en 2016

Identifying Minimal and Meaningful Change in PROMIS® for Rheumatoid Arthritis: Use of Multiple Methods and Perspectives

artículo científico publicado en 2020

International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials

artículo científico publicado en 2016

Investigating Dimensions of Stiffness in Rheumatoid and Psoriatic Arthritis: The Australian Rheumatology Association Database Registry and OMERACT Collaboration

artículo científico publicado en 2019

Measurement of minimal disease activity in psoriatic arthritis using PROMIS-Physical Function or the Health Assessment Questionnaire-Disability Index

artículo científico publicado en 2020

Outcomes of the 2019 GRAPPA Workshop on Continuous Composite Indices for the Assessment of Psoriatic Arthritis and Membership-recommended Next Steps

artículo científico publicado en 2020

Patient reported outcomes in rheumatoid arthritis clinical trials

artículo científico publicado en 2015

Patient-Reported Outcomes in Psoriatic Arthritis.

artículo científico publicado en 2016

Patient-reported outcomes and adult patients' disease experience in the idiopathic inflammatory myopathies. report from the OMERACT 11 Myositis Special Interest Group

artículo científico publicado en 2014

Proceedings of the 2019 GRAPPA Collaborative Research Network Meeting

artículo científico publicado en 2020

PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials

article

Reliability and Validity of Selected PROMIS Measures in People with Rheumatoid Arthritis

artículo científico publicado en 2015

Reply to Determinants of Early Morning Stiffness in Rheumatoid Arthritis

scientific article published on 30 July 2020

Reply to Morning Stiffness and Neutrophil Circadian Disarming

artículo científico publicado en 2020

Report of the GRAPPA-OMERACT Psoriatic Arthritis Working Group from the GRAPPA 2015 Annual Meeting

artículo científico publicado en 2016

Rheumatoid Arthritis Morning Stiffness Is Associated With Synovial Fibrin and Neutrophils

scientific article published on 12 February 2020

Stiffness Is the Cardinal Symptom of Inflammatory Musculoskeletal Diseases, Yet Still Variably Measured: Report from the OMERACT 2016 Stiffness Special Interest Group

artículo científico publicado en 2016

Systematic literature review of domains assessed in psoriatic arthritis to inform the update of the psoriatic arthritis core domain set

artículo científico publicado en 2016

Systematic review of treatment effectiveness and outcome measures for enthesitis in psoriatic arthritis

artículo científico publicado en 2014

Targeting extra-articular manifestations in PsA: a closer look at enthesitis and dactylitis

artículo científico publicado en 2015

The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set

artículo científico publicado en 2019

The GRAPPA-OMERACT Working Group: 4 Prioritized Domains for Completing the Core Outcome Measurement Set for Psoriatic Arthritis 2019 Updates

artículo científico publicado en 2020

Tofacitinib in the management of active psoriatic arthritis: patient selection and perspectives

artículo científico publicado en 2019

Towards improving measurement of stiffness in rheumatology

artículo científico publicado en 2018

Treatment Continuation Guidance in Psoriatic Arthritis Clinical Care

scientific article published on 01 November 2020

Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016.

artículo científico publicado en 2017

Using Acute-phase Reactants to Inform the Development of Instruments for the Updated Psoriatic Arthritis Core Outcome Measurement Set

article

Lista de obras de Ana-Maria Orbai

"Stiffness has different meanings, I think, to everyone": examining stiffness from the perspective of people living with rheumatoid arthritis

A Multicenter Nominal Group Study to Rank Outcomes Important to Patients, and Their Representation in Existing Composite Outcome Measures for Psoriatic Arthritis

A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiative ⬇️

Achieving minimal disease activity in psoriatic arthritis predicts meaningful improvements in patients’ health-related quality of life and productivity

Advancing Stiffness Measurement in Rheumatic Disease: Report from the Stiffness Special Interest Group at OMERACT 2018

Anti-C1q antibodies in systemic lupus erythematosus

Brief report: antisynthetase syndrome-associated myocarditis

Building a Citizen Pscientist: Advancing Patient-Centered Psoriasis Research by Empowering Patients as Contributors and Analysts

Classification and Outcome Measures for Psoriatic Arthritis

Combining online and in-person methods to evaluate the content validity of PROMIS fatigue short forms in rheumatoid arthritis

Comparing the patient reported physical function outcome measures in a real-life international cohort of patients with psoriatic arthritis

Content and Face Validity and Feasibility of 5 Candidate Instruments for Psoriatic Arthritis Randomized Controlled Trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting

Content validity of psoriatic arthritis composite indices: anchoring with the patient perspective and the core domain set

Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working Group

Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus

Determinants of Patient-Reported Psoriatic Arthritis Impact of Disease: An Analysis of the Association with Gender in 458 Patients from 14 Countries

Effect of Secukinumab on the Different GRAPPA-OMERACT Core Domains in Psoriatic Arthritis: A Pooled Analysis of 2049 Patients

Effect of filgotinib on health-related quality of life in active psoriatic arthritis: a randomized phase 2 trial (EQUATOR)

Efficacy and Safety of Ixekizumab in Patients with Psoriatic Arthritis and Inadequate Response to TNF Inhibitors: 3-Year Follow-Up (SPIRIT-P2)

Endorsement of the 66/68 Joint Count for the Measurement of Musculoskeletal Disease Activity: OMERACT 2018 Psoriatic Arthritis Workshop Report

Enhanced Patient Involvement and the Need to Revise the Core Set - Report from the Psoriatic Arthritis Working Group at OMERACT 2014

Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare Workshop

Fatigue numeric rating scale validity, discrimination and responder definition in patients with psoriatic arthritis

Feasibility and Domain Validation of Rheumatoid Arthritis (RA) Flare Core Domain Set: Report of the OMERACT 2014 RA Flare Group Plenary

GRAPPA-OMERACT initiative to standardise outcomes in psoriatic arthritis clinical trials and longitudinal observational studies

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis

Identifying Minimal and Meaningful Change in PROMIS® for Rheumatoid Arthritis: Use of Multiple Methods and Perspectives

International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials

Investigating Dimensions of Stiffness in Rheumatoid and Psoriatic Arthritis: The Australian Rheumatology Association Database Registry and OMERACT Collaboration

Measurement of minimal disease activity in psoriatic arthritis using PROMIS-Physical Function or the Health Assessment Questionnaire-Disability Index

Outcomes of the 2019 GRAPPA Workshop on Continuous Composite Indices for the Assessment of Psoriatic Arthritis and Membership-recommended Next Steps

Patient reported outcomes in rheumatoid arthritis clinical trials

Patient-Reported Outcomes in Psoriatic Arthritis.

Patient-reported outcomes and adult patients' disease experience in the idiopathic inflammatory myopathies. report from the OMERACT 11 Myositis Special Interest Group

Proceedings of the 2019 GRAPPA Collaborative Research Network Meeting

PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials

Reliability and Validity of Selected PROMIS Measures in People with Rheumatoid Arthritis

Reply to Determinants of Early Morning Stiffness in Rheumatoid Arthritis

Reply to Morning Stiffness and Neutrophil Circadian Disarming

Report of the GRAPPA-OMERACT Psoriatic Arthritis Working Group from the GRAPPA 2015 Annual Meeting

Rheumatoid Arthritis Morning Stiffness Is Associated With Synovial Fibrin and Neutrophils

Stiffness Is the Cardinal Symptom of Inflammatory Musculoskeletal Diseases, Yet Still Variably Measured: Report from the OMERACT 2016 Stiffness Special Interest Group

Systematic literature review of domains assessed in psoriatic arthritis to inform the update of the psoriatic arthritis core domain set

Systematic review of treatment effectiveness and outcome measures for enthesitis in psoriatic arthritis

Targeting extra-articular manifestations in PsA: a closer look at enthesitis and dactylitis

The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set

The GRAPPA-OMERACT Working Group: 4 Prioritized Domains for Completing the Core Outcome Measurement Set for Psoriatic Arthritis 2019 Updates

Tofacitinib in the management of active psoriatic arthritis: patient selection and perspectives

Towards improving measurement of stiffness in rheumatology

Treatment Continuation Guidance in Psoriatic Arthritis Clinical Care

Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016.

Using Acute-phase Reactants to Inform the Development of Instruments for the Updated Psoriatic Arthritis Core Outcome Measurement Set